Written by Eric Volkman for The Motley Fool ->
It had a good second quarter, fueled by sales growth in top blockbuster drugs.
It also topped analyst estimates for both revenue and profitability.
Sh
NA
Nasdaq News
31 Jul 2026 4 days ago 1 min read
Nasdaq News โ 31 July 2026
Text:
28 0 0
๐ Translate:
๐๏ธ AI Podcast โ Two-Host Discussion
Why AbbVie Stock Slumped Today
Kokoro TTS ยท ~5 min episode ยท American English voices
Choose voices for Host A and Host B. Changes take effect on next play.
A
Now Speaking
โ
Generating podcastโฆ
Synthesising speech โ will play automatically when readyโฆ
0:00 / 0:00
It had a good second quarter, fueled by sales growth in top blockbuster drugs.
It also topped analyst estimates for both revenue and profitability.